What is the share price of Bijoy Hans Ltd (BIJHANS) today?
The share price of BIJHANS as on 16th February 2026 is ₹52.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Bijoy Hans Ltd (BIJHANS) share?
The past returns of Bijoy Hans Ltd (BIJHANS) share are- Past 1 week: N/A%
- Past 1 month: 4.99%
- Past 3 months: 10.23%
- Past 6 months: 107.50%
- Past 1 year: 117.81%
- Past 3 years: 138.01%
- Past 5 years: 149.88%
What are the peers or stocks similar to Bijoy Hans Ltd (BIJHANS)?
The peers or stocks similar to Bijoy Hans Ltd (BIJHANS) include:What is the market cap of Bijoy Hans Ltd (BIJHANS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bijoy Hans Ltd (BIJHANS) is ₹37.58 Cr as of 16th February 2026.What is the 52 week high and low of Bijoy Hans Ltd (BIJHANS) share?
The 52-week high of Bijoy Hans Ltd (BIJHANS) is ₹52.60 and the 52-week low is ₹24.15.What is the PE and PB ratio of Bijoy Hans Ltd (BIJHANS) stock?
The P/E (price-to-earnings) ratio of Bijoy Hans Ltd (BIJHANS) is 268.39. The P/B (price-to-book) ratio is 10.64.Which sector does Bijoy Hans Ltd (BIJHANS) belong to?
Bijoy Hans Ltd (BIJHANS) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Bijoy Hans Ltd (BIJHANS) shares?
You can directly buy Bijoy Hans Ltd (BIJHANS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Bijoy Hans Ltd
BIJHANS Share Price
BSE₹52.600.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BIJHANS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
BIJHANS Performance & Key Metrics
BIJHANS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -39.97 | 10.64 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.47 | 5.75 | 0.59% |
BIJHANS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BIJHANS Company Profile
The Company offer various pharmaceutical formulations such as tablets, capsules, syrups, suspension and powders, focusing on segments such as ANTIBIOTICS, COUGH/COLD/ALLERGY, H-1RECEPTOR ANTAGONIST (ANTIULCERANT), NUTRACEUTICALS and NSAIDS
SUNPHARMA
PE Ratio
39.68
39.68
1Y Return
12.16%
12.16%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
77.45
77.45
1Y Return
42.41%
42.41%
Buy Reco %
81.48
81.48
DRREDDY
PE Ratio
18.95
18.95
1Y Return
14.89%
14.89%
Buy Reco %
51.61
51.61
CIPLA
PE Ratio
20.30
20.30
1Y Return
9.42%
9.42%
Buy Reco %
54.84
54.84
LUPIN
PE Ratio
32.08
32.08
1Y Return
14.56%
14.56%
Buy Reco %
72.22
72.22
BIJHANS Forecast
BIJHANS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BIJHANS
BIJHANS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
BIJHANS Income Statement
BIJHANS Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.12 | 0.13 | 0.15 | 0.14 | 0.10 | 0.74 | 0.05 | 0.03 | 0.02 | 0.05 | ||||||||||
Operating & Other expenses | 0.16 | 0.15 | 0.27 | 0.19 | 0.23 | 0.20 | 0.19 | 0.29 | 0.33 | 0.21 | ||||||||||
EBITDA | -0.04 | -0.02 | -0.12 | -0.05 | -0.13 | 0.54 | -0.14 | -0.26 | -0.31 | -0.16 | ||||||||||
| Depreciation/Amortization | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -0.06 | -0.04 | -0.12 | -0.06 | -0.14 | 0.53 | -0.14 | -0.26 | -0.31 | -0.16 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.06 | -0.04 | -0.13 | -0.06 | -0.14 | 0.53 | -0.15 | -0.26 | -0.31 | -0.16 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.06 | -0.04 | -0.13 | -0.06 | -0.14 | 0.53 | -0.21 | -0.26 | -0.31 | -0.16 | ||||||||||
| EPS | -0.18 | -0.12 | -0.42 | -0.18 | -0.47 | 1.78 | -0.68 | -0.84 | -0.41 | -0.22 |
BIJHANS Company Updates
BIJHANS Stock Peers
BIJHANS Past Performance & Peer Comparison
BIJHANS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bijoy Hans Ltd | 268.39 | 10.64 | — |
| Sun Pharmaceutical Industries Ltd | 39.68 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 77.45 | 19.50 | 0.73% |
| Dr Reddy's Laboratories Ltd | 18.95 | 3.16 | 0.62% |
BIJHANS Stock Price Comparison
Compare BIJHANS with any stock or ETFCompare BIJHANS with any stock or ETF
BIJHANS
BIJHANS Holdings
BIJHANS Shareholdings
BIJHANS Promoter Holdings Trend
BIJHANS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
BIJHANS Institutional Holdings Trend
BIJHANS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BIJHANS Shareholding Pattern
BIJHANS Shareholding Pattern
BIJHANS Shareholding History
BIJHANS Shareholding History
Foreign Institutions
smallcases containing BIJHANS stock
smallcases containing BIJHANS stock
Looks like this stock is not in any smallcase yet.
BIJHANS Events
BIJHANS Events
BIJHANS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIJHANS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BIJHANS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIJHANS has not given any dividends in last 5 years
BIJHANS Dividends
BIJHANS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBIJHANS Stock News & Opinions
BIJHANS Stock News & Opinions
Articles & Videos
Corporate
Bijoy Hans to convene board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 11 March 2026.Powered by Capital Market - Live
2 days agoCapital Market - Live
Corporate
Bijoy Hans to conduct board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 4 March 2026.Powered by Capital Market - Live
1 week agoCapital Market - Live
Earnings
Bijoy Hans reports standalone net loss of Rs 0.16 crore in the December 2025 quarter
Net loss of Bijoy Hans reported to Rs 0.16 crore in the quarter ended December 2025 as against net profit of Rs 0.53 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 as against Rs 0.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales00.13 -100 OPM %0-53.85 - PBDT-0.16-0.02 -700 PBT-0.16-0.03 -433 NP-0.160.53 PL Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Bijoy Hans to announce Quarterly Result
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Bijoy Hans to hold EGM
Bijoy Hans announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 25 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Bijoy Hans schedules EGM
Bijoy Hans announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Bijoy Hans reports standalone net loss of Rs 0.31 crore in the September 2025 quarter
Net Loss of Bijoy Hans reported to Rs 0.31 crore in the quarter ended September 2025 as against net loss of Rs 0.14 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 0.06 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales00.06 -100 OPM %0-283.33 - PBDT-0.31-0.13 -138 PBT-0.31-0.14 -121 NP-0.31-0.14 -121 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Bijoy Hans schedules board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 4 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Bijoy Hans to convene board meeting
Bijoy Hans will hold a meeting of the Board of Directors of the Company on 26 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Bijoy Hans to conduct AGM
Bijoy Hans announced that the 40th Annual General Meeting(AGM) of the company will be held on 25 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -8.43%, vs industry avg of 9.88%
Over the last 5 years, market share stayed at 0%